BR0103797A - Derivados de fenoxifenilheterociclila como ssris - Google Patents

Derivados de fenoxifenilheterociclila como ssris

Info

Publication number
BR0103797A
BR0103797A BR0103797-8A BR0103797A BR0103797A BR 0103797 A BR0103797 A BR 0103797A BR 0103797 A BR0103797 A BR 0103797A BR 0103797 A BR0103797 A BR 0103797A
Authority
BR
Brazil
Prior art keywords
heteroatoms
c6alkyl
nitrogen
heterocyclic ring
atoms
Prior art date
Application number
BR0103797-8A
Other languages
English (en)
Inventor
Mark David Andrews
David Hepworth
Donald Stuart Middleton
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021594A external-priority patent/GB0021594D0/en
Priority claimed from GB0105634A external-priority patent/GB0105634D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR0103797A publication Critical patent/BR0103797A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE FENOXIFENILHETEROCICLILA COMO SSRIs". A invenção proporciona compostos de fórmula geral ( I ) em que R^ 1^ 5 é H ou alquila C~ 1~-C~ 6~; R^ 2^ e R^ 3^, em conjunto com os átomos de interligação formam um anel saturado de 4 a 8 membros que contém um ou dois heteroátomos ( incluindo o nitrogênio ao qual R^ 2^ está ligado ) em que um segundo heteroátomo, se presente, é selecionado de entre oxigênio, nitrogênio e enxofre, com a condição de que o referido anel não pode conter dois heteroátomos adjacentes; Z é CF~ 3~, OCF~ 3~, alquiltio C~ 1~-C~ 6~ ou alcóxi C~ 1~-C~ 6~; Y é hidrogênio, halogêneo, -OR^ a^, R^ a^ ou alquiltio C~ 1~-C~ 6~ e em que R^ a^ é alquila C~ 1~-C~ 4~ facultativamente substituída com átomos de flúor; ou quando Z e Y estão ligados em para e meta em relação ao encadeamento de éter que liga os anéis A e B, Z e Y estão ligados de maneira que, em conjunto com os átomos de interligação, formam um anel carbocíclico ou heterocíclico de 5 a 7 membros condensado, o qual pode ser saturado, insaturado ou aromático, e em que quando Z e Y formam um anel heterocíclico, em adição a átomos de carbono, o encadeamento contém um ou dois heteroátomos independentemente selecionados de entre oxigênio, enxofre e nitrogênio; e Z e Y em conjunto não formam um anel fenilo condensado; R^ 4^ e R^ 5^, os quais podem ser iguais ou diferentes, são: A-X, em que A é igual a -CH=CH- ou -( CH~ 2~ )~ p~- onde p é 0, 1 ou 2; X é hidrogênio, F, CL, Br, L, CONR^ 6^R^ 7^, SO~ 2~NR^ 6^R^ 7^, SO~ 2~NHC(=O)R^ 6^, OH, alcóxi C~ 1~-C~ 4~, NR^ 8^SO~ 2~R^ 9^, NO~ 2~, NR^ 6^R^ 11^, CN, CO~ 2~R^ 10^, CHO, SR^ 10^, S(O)R^ 9^ ou SO~ 2~R^ 10^; ou um anel heterocíclico de 5 ou 6 membros contendo 1, 2 ou 3 heteroátomos selecionados de entre N, S e O facultativamente substituído independentemente por um ou mais R^ 13^; em que R^ 13^ é hidróxi, alcóxi C~ 1~-C~ 4~, F, alquila C~ 1~-C~ 6~, haloalquila, haloalcóxi, -NH~ 2~, -NH( alquila C~ 1~-C~ 6~ ) ou -N( alquila-C~ 1~-C~ 6~ )~ 2~.
BR0103797-8A 2000-08-31 2001-08-30 Derivados de fenoxifenilheterociclila como ssris BR0103797A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0021594A GB0021594D0 (en) 2000-08-31 2000-08-31 Diphenyl ether compounds useful in therapy
GB0105634A GB0105634D0 (en) 2001-03-07 2001-03-07 Novel compounds

Publications (1)

Publication Number Publication Date
BR0103797A true BR0103797A (pt) 2002-06-04

Family

ID=26244954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103797-8A BR0103797A (pt) 2000-08-31 2001-08-30 Derivados de fenoxifenilheterociclila como ssris

Country Status (7)

Country Link
EP (1) EP1184372B1 (pt)
JP (1) JP3802782B2 (pt)
AT (1) ATE324365T1 (pt)
BR (1) BR0103797A (pt)
CA (1) CA2356065C (pt)
DE (1) DE60119047D1 (pt)
MX (1) MXPA01008860A (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
ES2340130B1 (es) * 2008-11-27 2011-03-22 Consejo Superior De Investigaciones Cientificas (Csic) Funcionalizacion de 1-vinil-2 pirrolidona en posicion 3 mediante apertura de precursores ciclicos.
BR112013000602A2 (pt) * 2010-07-09 2016-07-05 Theravance Inc forma cristalina de um composto 3-fenoximetilpirrolidina
BR112021024108A2 (pt) 2019-05-31 2022-03-22 Ikena Oncology Inc Inibidores de tead e usos dos mesmos
MX2021014441A (es) 2019-05-31 2022-01-06 Ikena Oncology Inc Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
US20240083903A1 (en) * 2021-02-18 2024-03-14 Merck Sharp & Dohme Llc Aryl ether compounds as tead modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
GB2276162A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benazilide derivatives
HUP0105488A3 (en) * 1999-02-23 2005-07-28 Pfizer Prod Inc Monoamine reuptake inhibitors for treatment of cns disorders and pharmaceutical compositions containing the compounds

Also Published As

Publication number Publication date
JP2002114762A (ja) 2002-04-16
CA2356065C (en) 2005-04-12
EP1184372A1 (en) 2002-03-06
DE60119047D1 (de) 2006-06-01
CA2356065A1 (en) 2002-02-28
MXPA01008860A (es) 2002-08-20
ATE324365T1 (de) 2006-05-15
JP3802782B2 (ja) 2006-07-26
EP1184372B1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
UY26727A1 (es) Derivados de tropano útiles en terapia
UY28708A1 (es) Heterociclos sustituídos y usos de los mismos
AR009811A1 (es) Compuestos herbicidas, proceso para su produccion, proceso para la produccion de intermediarios, compuestos intermediarios para su exclusivo usoen dicho proceso, composicion que tiene actividad herbicida selectiva y proceso para el control selectivo de malas hierbas y gramineas en cultivos de planta
HRP20080070T3 (en) Pyrrazolo-pyrimidine derivatives
DE69402689D1 (de) 4-Benzoyl-Isoxazol Derivate, deren Herstellung und deren Verwendung als Herbizide
EA200300206A1 (ru) Производные феноксибензиламина в качестве ингибиторов повторного поглощения серотонина
ES523183A0 (es) Procedimiento para la preparacion de n-heterociclosulfonil-n'-pirimidinil-y-triacinil-ureas.
MX9204525A (es) Derivados de 4-benzoil-isoxasol, procedimiento para su preparacion y composicion herbicida que los contiene
CY1106398T1 (el) 6,7-διυδρο-5η-πυραζολο[1,2-α]πυραζολ-1-ονες οι οποιες ελεγχουν φλεγμονωδεις κυτοκινες
BR0208309A (pt) Derivados de arilisoxazolina, processos para a sua preparação e sua aplicação como composições praguicidas
BR0103797A (pt) Derivados de fenoxifenilheterociclila como ssris
AR057464A1 (es) Procedimiento para la preparacion de derivados de sulfonamida
HUP0303449A2 (hu) Szubsztituált benzofurán-2-karboxamid-származékok
DK1021421T3 (da) Amino- og hydroxy-substituerede triphenyl-S-triaziner som stabilisatorer
ES2125325T3 (es) Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
BG104471A (en) Benzylidene pyrazolones, their preparation and use as herbicides
AR037140A1 (es) Un compuesto de aminopirrol, su utilizacion, un procedimiento para producirlo y una composicion que lo comprende
ES2032461T3 (es) Procedimiento para preparar derivados de indol.
ATE18548T1 (de) Pyrrolidin-derivate, herstellung und verwendung als heilmittel.
DE69011714T2 (de) Kalziumantagonisten.
AR009934A1 (es) Compuesto fungicida arilacrilico, composicion fungicida que lo contiene y metodos de uso y sintesis
HRP20070542T3 (en) Sulfonamide derivatives for the treatment of diseases
CO4810228A1 (es) Derivados de pirazol piridazina, procesos para su preparacion y composiciones farmaceuticas que los contienen
ECSP992845A (es) Compuestos quimicos
ECSP993031A (es) Derivados de propenil cefalosporina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.